drugset / Trial / NCT01007383
LEO 27847 - A Study in Healthy Male Subjects
RandomizedSingle-groupDouble-blindOther
Summary
The purpose of this first-in-man trial is to determine the safety and tolerability of ascending single and multiple doses of LEO 27847 in healthy male subjects. The trial will be performed in two parts. In Part 1, single doses of LEO 27847 will be administered to healthy male subjects. In Part 2, multiple doses of LEO 27847 will be administered to healthy male subjects.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEO 27847 | Unknown | — | Oral |
Indications
No indication recorded.